CD3 zeta chain (CD247) (CD3ζ)

The CD3 zeta chain (CD247) is a fundamental component of the T-cell receptor (TCR) complex, providing the primary intracellular signaling required for T-cell activation. In the context of chimeric antigen receptor (CAR) engineering, the cytoplasmic domains of CD3 zeta are incorporated into the synthetic CAR construct to provide 'Signal 1' upon antigen recognition [2][3]. When expressed in gamma-delta (γδ) T cells, these domains allow the cells to bypass traditional MHC-restricted antigen presentation, leveraging the innate-like cytotoxic properties of the γδ lineage [2]. This approach is particularly valuable in developing 'off-the-shelf' allogeneic therapies, as γδ T cells have a significantly lower risk of inducing graft-versus-host disease (GvHD) compared to alpha-beta T cells [4]. Therapeutically, the CD3 zeta domain is the engine of CAR-T cell potency, triggering the release of perforins, granzymes, and pro-inflammatory cytokines to eliminate target cells. While most commonly associated with hematological malignancies like B-cell lymphomas, γδ CAR-T cells utilizing CD3 signaling are increasingly being investigated for solid tumor applications [2][4]. The interaction between the CAR's extracellular binding domain and the intracellular CD3 zeta signaling tail ensures that the engineered cell responds specifically to the presence of the target biomarker. Monitoring the activity of this signaling pathway is crucial for managing safety risks such as Cytokine Release Syndrome (CRS) and ensuring long-term therapeutic persistence [3].

Other names

CD247T-cell receptor T3 zeta chainCD3ZCD3-zetaT-cell surface glycoprotein CD3 zeta chainCD3 cytoplasmic domain

The CD3 zeta cytoplasmic domain contains three Immunoreceptor Tyrosine-based Activation Motifs (ITAMs) that, upon phosphorylation by Src-family kinases such as Lck, recruit the tyrosine kinase ZAP-70 to initiate downstream signaling cascades for T-cell activation and effector function [1][3].